Healthcare Dec 28, 2021 11:33 AM (GMT+8) · EqualOcean
On December 28, 2021, Auscon biology (Nantong) Co., Ltd. announced the completion of a new round of financing of RMB 1.5 billion. This round of financing was led by shareholders Jinshi investment and CDH Baifu, followed by a number of well-known institutions, and Yikai capital acted as the exclusive financial adviser in this transaction. Aosikang biology is a cdmo and culture medium Biotechnology enterprise in China, focusing on the business related to biopharmaceutical production and can provide services to customers "R & D - process - production - Logistics - Technical Support - after-sales" one-stop service.